What Is a Cavernoma and How Does It Differ from an Aneurysm?
A cerebral cavernous malformation is a lesion made of thin-walled, dilated vascular spaces filled with slowly flowing blood, and it is not directly connected to the brain's artery-vein circulation; this makes it a low-pressure structure. This feature distinguishes a cavernoma from a brain aneurysm or arteriovenous malformation (AVM), which are high-pressure and carry a risk of sudden large bleeding. Cavernomas may be single or multiple; most are incidental, but in familial (hereditary) forms multiple lesions can be seen. The most common symptoms are seizures (especially in cavernomas near the brain surface), headache due to bleeding, and neurological symptoms depending on the lesion's location (changes in strength, sensation or vision). The most sensitive method in diagnosis and follow-up is special MRI sequences that show even small traces of bleeding (gradient echo / SWI). A correct diagnosis requires distinguishing a cavernoma from other bleeding lesions and from tumours.
Understanding the Bleeding Risk
At the heart of managing a cavernoma lies a realistic assessment of bleeding risk. Unlike aneurysm bleeding, cavernoma bleeds are usually low-pressure, small and often non-fatal; however, if they lie in a critical region such as the brainstem, even a small bleed can cause serious symptoms. The main factors affecting bleeding risk are: whether it has bled before (a cavernoma that has bled has a higher chance of re-bleeding than one that never has), the location of the lesion (brainstem and deep-seated ones are riskier), and whether it is familial/multifocal. The annual bleeding risk of a superficial cavernoma that has never bled and causes no symptoms is relatively low; for this reason such lesions are mostly observed. What matters is calculating the risk individually for each patient — without exaggerating it but also without underestimating it. The fear of 'a tangle of vessels in my brain' is often greater than the real risk; correct information is part of treatment.
Surveillance or Surgery? How Is the Decision Made?
There is no single right answer in treating a cavernoma; the decision is made by comparing the lesion's risk profile with the risk of surgery. Surveillance (follow-up) comes to the fore in these situations: cavernomas that have never bled, cause no symptoms, or lie in a deep or critical region where surgery would be risky are followed with regular MRI. Surgery (removal by microsurgery) comes into play for cavernomas that have had repeated bleeding, cause drug-resistant seizures, produce progressive neurological symptoms, and can be safely reached surgically. Brainstem cavernomas are a special group: because surgery there is high-risk, it is generally done only in cases that have re-bled and are symptomatic, in experienced hands and where there is a safe corridor. Unlike an aneurysm, cavernomas are generally not suitable for endovascular (catheter) treatment; treatment is either surveillance or microsurgery. Gamma Knife plays a limited and controversial role in cavernomas and is not routinely recommended. The decision is always made by weighing the patient's symptoms, the lesion's location and personal preferences together.
Microsurgery: When and How?
When a decision for surgery is made, the aim is to completely remove the cavernoma while causing the least damage to the surrounding healthy brain tissue; because residual cavernoma tissue can bleed again. Before surgery the lesion's location is mapped with neuronavigation and, where needed, DTI tractography; in cavernomas near functional areas the motor and language pathways are identified. Surgery is performed under the microscope, reaching the lesion via the safest corridor; neuromonitoring and, where needed, awake surgery are used for lesions adjacent to functional areas. Surgery for superficial, accessible cavernomas is generally low-risk and highly successful; once removed, the bleeding risk is eliminated and seizures may be markedly reduced. In deep cavernomas such as those in the brainstem, surgery is far more delicate and is performed only if there is a safe point where the lesion reaches the brain surface. Operating time and hospital stay vary with the lesion's location; in superficial cases recovery is quick.
Risks and Realistic Expectations
In managing a cavernoma, both surveillance and surgery have their own benefits and risks, which must be discussed honestly. With surveillance the lesion may bleed over time; for this reason follow-up must be carried out diligently and any new symptoms assessed promptly. With surgery there is a risk, depending on the lesion's location, of bleeding, infection and temporary or permanent neurological deficit (especially in brainstem and functional-area cavernomas). As a general rule, removing a superficial, symptomatic cavernoma is both safe and curative; in a deep, critically located cavernoma that has never bled, surveillance is often the more sensible choice. Surgery can reduce seizures but does not always eliminate them entirely; permanent neurological losses present before surgery may not fully reverse. In no case is it guaranteed that it 'will never bleed' or that 'seizures will completely resolve'; the decision and expectations are shared openly with the patient and family along with the lesion's risk profile.